Year |
Citation |
Score |
2017 |
Sundriyal S, Chen PB, Lubin AS, Lueg GA, Li F, White AJP, Malmquist NA, Vedadi M, Scherf A, Fuchter MJ. Histone lysine methyltransferase structure activity relationships that allow for segregation of G9a inhibition and anti-Plasmodium activity. Medchemcomm. 8: 1069-1092. PMID 29308121 DOI: 10.1039/C7Md00052A |
0.355 |
|
2017 |
Sundriyal S, Moniot S, Mahmud Z, Yao S, Di Fruscia P, Reynolds CR, Dexter DT, Sternberg MJ, Lam EW, Steegborn C, Fuchter MJ. Thienopyrimidinone based sirtuin-2 (SIRT2)-selective inhibitors bind in the ligand induced 'selectivity pocket'. Journal of Medicinal Chemistry. PMID 28135086 DOI: 10.1021/Acs.Jmedchem.6B01690 |
0.344 |
|
2015 |
Malmquist NA, Sundriyal S, Caron J, Chen P, Witkowski B, Menard D, Suwanarusk R, Renia L, Nosten F, Jiménez-Díaz MB, Angulo-Barturen I, Santos Martínez M, Ferrer S, Sanz LM, Gamo FJ, et al. Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans. Antimicrobial Agents and Chemotherapy. 59: 950-9. PMID 25421480 DOI: 10.1128/Aac.04419-14 |
0.306 |
|
2014 |
Srimongkolpithak N, Sundriyal S, Li F, Vedadi M, Fuchter MJ. Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors†Electronic supplementary information (ESI) available. See DOI: 10.1039/c4md00274a. Medchemcomm. 5: 1821-1828. PMID 25750706 DOI: 10.1039/C4Md00274A |
0.311 |
|
2014 |
Sundriyal S, Malmquist NA, Caron J, Blundell S, Liu F, Chen X, Srimongkolpithak N, Jin J, Charman SA, Scherf A, Fuchter MJ. Development of diaminoquinazoline histone lysine methyltransferase inhibitors as potent blood-stage antimalarial compounds. Chemmedchem. 9: 2360-73. PMID 25044750 DOI: 10.1002/Cmdc.201402098 |
0.35 |
|
2011 |
Nair SC, Brooks CF, Goodman CD, Sturm A, Strurm A, McFadden GI, Sundriyal S, Anglin JL, Song Y, Moreno SN, Striepen B. Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii. The Journal of Experimental Medicine. 208: 1547-59. PMID 21690250 DOI: 10.1084/Jem.20110039 |
0.313 |
|
2010 |
Kasetti Y, Patel NK, Sundriyal S, Bharatam PV. Conformational polymorphism in sulfonylurea drugs: electronic structure analysis. The Journal of Physical Chemistry. B. 114: 11603-11. PMID 20718444 DOI: 10.1021/Jp101327K |
0.661 |
|
2010 |
Kasetti Y, Patel NK, Sundriyal S, Bharatam PV. Conformational polymorphism in sulfonylurea drugs: Electronic structure analysis Journal of Physical Chemistry B. 114: 11603-11611. DOI: 10.1021/jp101327k |
0.668 |
|
2010 |
Sundriyal S, Viswanad B, Ramarao P, Chakraborti AK, Bharatam PV. Corrigendum to “New PPARγ ligands based on barbituric acid: Virtual screening, synthesis and receptor binding studies” [Bioorg. Med. Chem. Lett. 18 (2008) 4959] Bioorganic & Medicinal Chemistry Letters. 20: 424. DOI: 10.1016/J.Bmcl.2009.11.002 |
0.498 |
|
2009 |
Deng L, Sundriyal S, Rubio V, Shi ZZ, Song Y. Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase. Journal of Medicinal Chemistry. 52: 6539-42. PMID 19888756 DOI: 10.1021/Jm9012592 |
0.321 |
|
2009 |
Sundriyal S, Bharatam PV. Important pharmacophoric features of pan PPAR agonists: common chemical feature analysis and virtual screening. European Journal of Medicinal Chemistry. 44: 3488-95. PMID 19268404 DOI: 10.1016/J.Ejmech.2009.01.024 |
0.318 |
|
2008 |
Sundriyal S, Viswanad B, Ramarao P, Chakraborti AK, Bharatam PV. New PPARgamma ligands based on barbituric acid: virtual screening, synthesis and receptor binding studies. Bioorganic & Medicinal Chemistry Letters. 18: 4959-62. PMID 18752947 DOI: 10.1016/J.Bmcl.2008.08.028 |
0.54 |
|
2008 |
Sundriyal S, Viswanad B, Bharathy E, Ramarao P, Chakraborti AK, Bharatam PV. New PPARgamma ligands based on 2-hydroxy-1,4-naphthoquinone: computer-aided design, synthesis, and receptor-binding studies. Bioorganic & Medicinal Chemistry Letters. 18: 3192-5. PMID 18482837 DOI: 10.1016/J.Bmcl.2008.04.072 |
0.541 |
|
2008 |
Bharatam PV, Patel DS, Adane L, Mittal A, Sundriyal S. Modeling and informatics in designing anti-diabetic agents. Current Pharmaceutical Design. 13: 3518-30. PMID 18220788 DOI: 10.2174/138161207782794239 |
0.317 |
|
2008 |
Sundriyal S, Khanna S, Saha R, Bharatam PV. Metformin and glitazones: does similarity in biomolecular mechanism originate from tautomerism in these drugs? Journal of Physical Organic Chemistry. 21: 30-33. DOI: 10.1002/Poc.1273 |
0.638 |
|
2006 |
Bharatam PV, Sundriyal S. Molecular electrostatic potentials in the design of dendrimers for the delivery of glitazones. Journal of Nanoscience and Nanotechnology. 6: 3277-82. PMID 17048547 DOI: 10.1166/Jnn.2006.473 |
0.427 |
|
2006 |
Sundriyal S, Sharma RK, Jain R. Current advances in antifungal targets and drug development. Current Medicinal Chemistry. 13: 1321-35. PMID 16712473 DOI: 10.2174/092986706776873023 |
0.312 |
|
Show low-probability matches. |